Insilico Medicine, whose Hong Kong IPO application lapsed in 2024, is still considering going public in the city, said ...

This link in the pharma supply chain is undergoing a major transformation propelled by technological advancements, regulatory ...

In the second part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Jason C. Foster, CEO of Ori Biotech, ...

Tyr Pharma (ATYR) announced a publication demonstrating the mechanism of action for its lead therapeutic candidate, efzofitimod, in the journal ...

Domestic drug companies in India are preparing to launch affordable generics of the diabetes drug Empagliflozin after the ...

The companies agreed to share profits for the therapy equally in the U.S. and Europe, but Roche will have exclusive rights to ...

ABUJA, NIGERIA / ACCESS Newswire / March 11, 2025 / In a landmark effort to transform Nigeria's pharmaceutical industry and ...

Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company, today announced positive topline results from its ...

Ionis Pharmaceuticals Inc (NASDAQ:IONS) and Ono Pharmaceutical Co., Ltd entered into a license agreement in which Ono obtains ...

Peer-reviewed publication validates efzofitimod's unique anti-inflammatory mechanism of action on macrophages through ...